SMARCA1 and liver cancer: Extending these results, we established SNF2L-overexpressing HCCLM3 liver cancer cells (a SNF2L-deficient cell line) with stable SNF2L cDNA expression (Fig. 2H, uncropped original western blots Fig. 2H).